Key result
Neoplastic pericardial effusion management lacks controlled trials and relies on individualized therapies like pericardiocentesis.
Population
Patients with neoplastic pericardial disease, particularly metastatic cancer to the pericardium causing…
Design
Review
Authors
Loading...
Without trial data, neoplastic effusion care stays individualized by prognosis; leaves open need for prospective studies to standardize therapy.
Management of neoplastic pericardial effusion relies on individualized approaches such as pericardiocentesis and catheter drainage, as no controlled clinical trials exist to guide therapy.
E. William Hancock (1990) conducted a review in Neoplastic Pericardial Disease. Pericardiocentesis and local therapies was evaluated. Management of neoplastic pericardial effusion lacks controlled clinical trials, relying on individualized therapies like pericardiocentesis based on patient condition and systemic disease prognosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: